Literature DB >> 30443780

Outpatient parenteral antimicrobial therapy and antibiotic stewardship: opponents or teammates?

Ester Steffens1,2, Charlotte Quintens3, Inge Derdelinckx4,5, Willy E Peetermans4,5, Johan Van Eldere5,6, Isabel Spriet3, Annette Schuermans7,8.   

Abstract

PURPOSE: This narrative review aims to describe barriers of outpatient parenteral antimicrobial therapy at home (OPAT), potentially compromising general standards of antibiotic stewardship (ABS) and facilitators of OPAT for ABS.
METHODS: After a literature review, five authors determined the barriers and facilitators to discuss in this review.
RESULTS: Sixty-six publications were included in the narrative review and seven barriers and five facilitators are discussed in this article. The impracticability of multiple daily dosing during OPAT, the impact of real-life temperature variations, deviations of the infusion rates of elastomeric devices, access to prolonged intravenous antibiotic therapy, not administering loading doses before the initiation of extended or continuous infusions and the transmural nature of care associated with OPAT, can lead to deviations of recommended treatment regimens and sub-optimal clinical and laboratory follow-up, with a risk of inferior clinical outcomes, adverse events, drug-resistance and higher costs. On the other hand, OPAT provides access to treatments with intravenous antibiotics and simultaneously avoids prolonged hospitalization.
CONCLUSION: Implementing ABS guidelines in OPAT programs, e.g., by using a multidisciplinary team approach and facility-specific protocols for OPAT with patient selection criteria and instructions for selection, storage, preparation and administration of antibiotics, can improve appropriate antibiotic use. Additionally, further research should examine the effectiveness of these interventions on outcomes of OPAT.

Entities:  

Keywords:  Antibiotics; Antimicrobial stewardship; Home care; Infectious diseases; Outpatient parenteral antimicrobial therapy

Mesh:

Substances:

Year:  2018        PMID: 30443780     DOI: 10.1007/s15010-018-1250-1

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  75 in total

1.  Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients.

Authors:  C J Donskey; T K Chowdhry; M T Hecker; C K Hoyen; J A Hanrahan; A M Hujer; R A Hutton-Thomas; C C Whalen; R A Bonomo; L B Rice
Journal:  N Engl J Med       Date:  2000-12-28       Impact factor: 91.245

2.  The efficacy of continuous infusion flucloxacillin in home therapy for serious staphylococcal infections and cellulitis.

Authors:  B P Howden; M J Richards
Journal:  J Antimicrob Chemother       Date:  2001-08       Impact factor: 5.790

3.  Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines.

Authors:  Alan D Tice; Susan J Rehm; Joseph R Dalovisio; John S Bradley; Lawrence P Martinelli; Donald R Graham; R Brooks Gainer; Mark J Kunkel; Robert W Yancey; David N Williams
Journal:  Clin Infect Dis       Date:  2004-05-26       Impact factor: 9.079

Review 4.  Management of bone and joint infections due to Staphylococcus aureus.

Authors:  J S Davis
Journal:  Intern Med J       Date:  2005-12       Impact factor: 2.048

5.  Stability and compatibility of ceftazidime administered by continuous infusion to intensive care patients.

Authors:  H Servais; P M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

6.  Stability and compatibility study of cefepime in comparison with ceftazidime for potential administration by continuous infusion under conditions pertinent to ambulatory treatment of cystic fibrosis patients and to administration in intensive care units.

Authors:  Nariné Baririan; Hugues Chanteux; Eric Viaene; Hélène Servais; Paul M Tulkens
Journal:  J Antimicrob Chemother       Date:  2003-03       Impact factor: 5.790

7.  Comparative stability studies of antipseudomonal beta-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units).

Authors:  Eric Viaene; Hugues Chanteux; Hélène Servais; Marie-Paule Mingeot-Leclercq; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

8.  Impact of mandatory inpatient infectious disease consultation on outpatient parenteral antibiotic therapy.

Authors:  Rajendra Sharma; William Loomis; Richard B Brown
Journal:  Am J Med Sci       Date:  2005-08       Impact factor: 2.378

Review 9.  Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid.

Authors:  William A Craig
Journal:  Infect Dis Clin North Am       Date:  2003-09       Impact factor: 5.982

10.  Out of hospital treatment of patients with melioidosis using ceftazidime in 24 h elastomeric infusors, via peripherally inserted central catheters.

Authors:  Sarah Huffam; Susan P Jacups; Paulene Kittler; Bart J Currie
Journal:  Trop Med Int Health       Date:  2004-06       Impact factor: 2.622

View more
  8 in total

1.  Clinical effectiveness of oral antimicrobial therapy for acute pyelonephritis caused by extended-spectrum β-lactamase-producing Enterobacteriales.

Authors:  Si-Ho Kim; Kyoung Ree Lim; Hyunju Lee; Kyungmin Huh; Sun Young Cho; Cheol-In Kang; Doo Ryeon Chung; Kyong Ran Peck
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-09-13       Impact factor: 3.267

2.  Implementing a Personalized Antimicrobial Stewardship Program for Women with Gynecological Cancers and Healthcare-Associated Infections.

Authors:  Simona Di Giambenedetto; Alberto Borghetti; Lorena Quagliozzi; Valeria Gallucci; Francesca Lombardi; Arturo Ciccullo; Anna Fagotti; Enrica Tamburrini; Giovanni Scambia
Journal:  J Pers Med       Date:  2022-04-18

3.  Ampicillin and Ceftriaxone Solution Stability at Different Temperatures in Outpatient Parenteral Antimicrobial Therapy.

Authors:  L Herrera-Hidalgo; L E López-Cortes; R Luque-Márquez; J Gálvez-Acebal; A de Alarcón; L F López-Cortes; A Gutiérrez-Valencia; M V Gil-Navarro
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

4.  Overcoming stability challenges during continuous intravenous administration of high-dose amoxicillin using portable elastomeric pumps.

Authors:  Guillaume Binson; Claire Grignon; Gwenaël Le Moal; Pauline Lazaro; Jérémy Lelong; France Roblot; Nicolas Venisse; Antoine Dupuis
Journal:  PLoS One       Date:  2019-08-16       Impact factor: 3.240

5.  Nurse roles in antimicrobial stewardship: lessons from public sectors models of acute care service delivery in the United Kingdom.

Authors:  Enrique Castro-Sánchez; Mark Gilchrist; Raheelah Ahmad; Molly Courtenay; Jo Bosanquet; Alison H Holmes
Journal:  Antimicrob Resist Infect Control       Date:  2019-10-22       Impact factor: 4.887

Review 6.  Clinic- and Hospital-Based Home Care, Outpatient Parenteral Antimicrobial Therapy (OPAT) and the Evolving Clinical Responsibilities of the Pharmacist.

Authors:  Toni Docherty; Jennifer J Schneider; Joyce Cooper
Journal:  Pharmacy (Basel)       Date:  2020-12-07

7.  Recent Updates in Antimicrobial Stewardship in Outpatient Parenteral Antimicrobial Therapy.

Authors:  Monica V Mahoney; Lindsey M Childs-Kean; Parisa Khan; Christina G Rivera; Ryan W Stevens; Keenan L Ryan
Journal:  Curr Infect Dis Rep       Date:  2021-11-09       Impact factor: 3.725

8.  Antimicrobial stewardship in the outpatient parenteral antimicrobial therapy (OPAT) setting: the impact of prescription assessment by an infectious diseases specialist.

Authors:  Valéria Cassettari; Newton Novato; Maria Helena Flesch Onuchic
Journal:  Braz J Infect Dis       Date:  2021-03-11       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.